A recent systematic review indicated that there were limited data to indicate that treatment was effective in reducing fractures in men.(12) Specifically, there have been two trials testing the efficacy of alendronate,(13,14) two of risedronate,(15,16) and two of parathyroid hormone(17,18) in men with osteoporosis. Here, PTH is linked to osteoporosis.